AA amyloidosis associated with morbid obesity (clinical case)

被引:1
作者
Beridze Vaktangova, Nana [1 ]
Garcia Moreira, Vanesa [1 ]
Garcia Castanon, Sandra [1 ]
Rodriguez Aguilar, Raul [2 ]
Dominguez Iglesias, Francisco [2 ]
机构
[1] Cabuenes Hosp, Clin Anal Serv, Gijon 33394, Asturias, Spain
[2] Cabuenes Hosp, Pathol Anat Serv, Gijon, Asturias, Spain
来源
REUMATOLOGIA CLINICA | 2020年 / 16卷 / 06期
关键词
Amyloidosis; Obesity; Familial Mediterranean fever; SECONDARY; PATIENT;
D O I
10.1016/j.reuma.2018.09.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We present the case of a 45-year-old woman who was hospitalized due to severe macrocytic anemia and renal failure. The patient presented a morbid obesity. The immunological study showed anti-ENA anti-SSA (Ro52) positive, with negative antinuclear antibodies. Also in the proteinogram (serum immunofixation) the presence of monoclonal bands IgG lambda and IgG kappa, monoclonal component 7.2% (4.68 g/L), with elevation of free light chains (kappa 95.94 mg/L (3.3-19.4), evidenced, lambda 145.17 mg/L (5.71-26.3)). The bone marrow study showed an infiltration of 5% of plasma cells and positive for AA amyloid. Finally, a percutaneous renal biopsy was performed, which again showed amyloid infiltration. In the genetic study, 2 mutations of the family Mediterranean fever gene (MEFV) have been identified. Secondary AA amyloidosis has been described associated with obesity, in addition to a percentage of cases of unknown etiology. (C) 2018 Elsevier Espana, S.L.U. and Sociedad Espanola de Reumatologia y Colegio Mexicano de Reumatologia. All rights reserved.
引用
收藏
页码:493 / 496
页数:4
相关论文
共 12 条
  • [1] A severe autosomal-dominant periodic inflammatory disorder with renal AA amyloidosis and colchicine resistance associated to the MEFV H478Y variant in a Spanish kindred:: An unusual familial Mediterranean fever phenotype or another MEFV-associated periodic inflammatory disorder?
    Aldea, A
    Campistol, JM
    Arostegui, JI
    Rius, J
    Maso, M
    Vives, J
    Yagüe, J
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2004, 124A (01): : 67 - 73
  • [2] Alsina E, 2009, CLIN NEPHROL, V72, P312
  • [3] [Anonymous], 2012, PLOS ONE
  • [4] [Anonymous], 2018, CLIN NEPHROL
  • [5] Risk factors for subclinical inflammation in children with Familial Mediterranean fever
    Bayram, Meral Torun
    Cankaya, Tufan
    Bora, Elcin
    Kavukcu, Salih
    Ulgenalp, Ayfer
    Soylu, Alper
    Turkmen, Mehmet
    [J]. RHEUMATOLOGY INTERNATIONAL, 2015, 35 (08) : 1393 - 1398
  • [6] Clinical evaluation of R202Q alteration of MEFV genes in Turkish children
    Comak, Elif
    Akman, Sema
    Koyun, Mustafa
    Dogan, Cagla Serpil
    Gokceoglu, Arife Uslu
    Arikan, Yunus
    Keser, Ibrahim
    [J]. CLINICAL RHEUMATOLOGY, 2014, 33 (12) : 1765 - 1771
  • [7] Complete Remission of Nephrotic Syndrome Secondary to Amyloid A Amyloidosis in Patient with Inactive Crohn's Disease after Treatment by Infliximab
    Hassani, Kawtar
    Hamzi, Mohamed Amine
    El Kabbaj, Driss
    [J]. SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2018, 29 (02) : 456 - 461
  • [8] Efficacy of anakinra in a patient with systemic amyloidosis presenting as amyloidoma
    Nalcacioglu, Hulya
    Ozkaya, Ozan
    Genc, Gurkan
    Ayyildiz, Suat
    Kefeli, Mehmet
    Elli, Murat
    Aydin, Oguz
    Ceyhan Bilgici, Meltem
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2018, 21 (02) : 552 - 559
  • [9] AA amyloidosis - Benefits and prospects of IL-6 inhibitors
    Okuda, Yasuaki
    [J]. MODERN RHEUMATOLOGY, 2019, 29 (02) : 268 - 274
  • [10] Modern Approaches to the Treatment of Amyloidosis: The Critical Importance of Early Detection in Surgical Pathology
    Picken, Maria M.
    [J]. ADVANCES IN ANATOMIC PATHOLOGY, 2013, 20 (06) : 424 - 439